Spain PharmaMar, a Spanish firm, is beginning Phase II clinical trials for its anti-tumour drug Aplidin to treat coronavirus. The firm’s stocks have soared on the news.   PharmaMar is joining the race to find a treatment for COVID1-9. The Madrid-based company that developed multiple myeloma therapy Aplidin (plitidepsin) announced that…

Spain Building on the topics covered in our March 2019 report, the latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the broader Spanish life sciences value chain.   With the Iberian nation enjoying an economic rebound, pharmaceutical multinationals are once again seeing Spain as a…

Spain Though still one of the younger and lesser-known outfits inhabiting the European drug development landscape, Irish-headquartered rare disease specialist, Jazz pharma has been making tremendous headway in the onco-haematology and sleep disorder spaces and the Spanish affiliate is absolutely no exception.   We blend the lessons of art with our…

Spain In what is a highly competitive and crowded women’s health field in Spain, smaller players are having to be increasingly focused and specialised to carve out a market share.   The [Spanish women’s health] market is very competitive since there are many companies and the sector is overwhelmingly a business…

Spain Many of the world’s mega-rich are increasingly active philanthropists in the healthcare arena and Spain is no exception with Galician billionaire Amancio Ortega Gaona, the 82-year-old owner of clothing empire Inditex Fashion Group, which comprises iconic brands such as Zara and Massimo Dutti, embarking upon something of a spending spree…

Spain The global acquisition of GSK’s thrombosis portfolio and subsequent purchase of AstraZeneca’s anaesthesia business have been critical milestones for the maverick South African pharmaceutical outfit Aspen, enabling the company to establish a consolidated presence across Europe, including the opening of the firm’s first-ever Spanish affiliate only two and a half…

Spain Perhaps the only CEO of a dermo-cosmetics company with a PhD in astrophysics and space technology as well as three years working at NASA under his belt, Isdin’s Juan Naya feels he is uniquely positioned to lead a firm creating products that protect against the sun’s rays.   It was…

Spain The North-Eastern region of Catalonia is one of Spain’s most prosperous and has been allocating increasingly large amounts of its budget towards healthcare. With strong government backing and a robust enabling ecosystem, the region is now aiming to embrace cutting edge areas such as personalised medicine.   Healthcare a Priority…

Spain Esteve has long been a family-run business, though in early 2018 the Spanish champion decided to make a daring, though calculated, move and positioned the then CCO of Lundbeck, Staffan Schüberg, as their new CEO.   We have world-class experience [in neuroscience and gene therapy] and we see these areas…

Spain Despite the Spanish economy and pharmaceutical market’s steady growth, many local players are becoming cognizant of the limitations and risks of operating within a single market. Therefore, these small to mid-cap local companies are taking the next logical steps in their growth; internationalization.   The financial crisis in 2008 pushed…

Spain With cost pressures mounting, Spain is increasingly turning towards digital solutions to maintain the high levels of care provided by its healthcare system.   Spain is at a point of disruption in which the healthcare system is facing big challenges; the solution to which has to be technology Angeles Delgado,…

Spain Spanish pharma is performing well-above other industries in terms of the percentage of women it employs in leadership positions. Spanish-native Belén Garijo,  global CEO of Merck Healthcare since January 2015, is at the forefront of this trend, flying the flag for both Spain as a whole as well as the…